Artificial intelligence biomarker detects high-risk childhood asthma subgroup for respiratory infections and exacerbations
Journal of Allergy and Clinical Immunology · 2025-12 · 156 (6) · 1547-1555.e4
DOI: 10.1016/j.jaci.2025.07.031 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Allergy and Clinical Immunology, 2025-12. Verfasst von Young J Juhn und 22 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatric and Adolescent Medicine, Mayo Clinic, Rochester, Minn; Precision Population Science Lab, Mayo Clinic, Rochester, Minn. Electr…. Hauptthemen laut MEDLINE: Asthma, Respiratory Tract Infections, Artificial Intelligence. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS, NIAID NIH HHS, National Institutes of Health.
Abstract (Originalsprache)
BACKGROUND: Asthma is associated with an increased risk of acute respiratory infections (ARI). Little is known about whether natural language processing (NLP)-powered digital biomarkers can identify a high-risk asthma subgroup for ARI during early childhood. OBJECTIVE: We assessed whether a digital biomarker could identify a high-risk subgroup of childhood asthma for ARI. METHODS: We applied validated NLP algorithms for Predetermined Asthma Criteria (NLP-PAC) and Asthma Predictive Index (NLP-API) to electronic health records of the 1997-2016 Mayo Clinic Birth Cohort. We categorized the cohort into 4 subgroups: both criteria positive (NLP-PAC+/NLP-API+), PAC positive only (NLP-PAC+), API positive only (NLP-API+), and both criteria negative (NLP-PAC-/NLP-API-). We assessed the risk of 5 medically attended ARI (pneumonia, frequent group A streptococcal pharyngeal infection, Bordetella pertussis, influenza A/B, and respiratory syncytial virus infection) and asthma exacerbation defined by NLP algorithms at 3 years of age among the 4 subgroups. We also examined whether such associations emerged during the first 3 years of life. RESULTS: There were 22,370 eligible subjects (51% male and 81% White). The NLP-PAC+/NLP-API+ subgroup had the highest risk of pneumonia, influenza A/B, and asthma exacerbation compared to other groups. No significant differences were found in other ARI. The same subgroup had the highest occurrence of pneumonia, influenza A/B, and respiratory syncytial virus infection, compared to other groups, during the first 3 years of life. CONCLUSION: NLP-PAC+/NLP-API+ can be a novel digital biomarker for a high-risk subgroup of childhood asthma for pneumonia, influenza A/B, and asthma exacerbation. This phenotype may emerge early in life.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pediatric and Adolescent Medicine, Mayo Clinic, Rochester, Minn; Precision Population Science Lab, Mayo Clinic, Rochester, Minn. Electronic address: Juhn.young@mayo.edu.
- Department of Pediatric and Adolescent Medicine, Mayo Clinic, Rochester, Minn; Precision Population Science Lab, Mayo Clinic, Rochester, Minn.
- Department of Quantitative Health Sciences, Mayo Clinic, Rochester, Minn.
- Department of Artificial Intelligence and Informatics, Mayo Clinic, Rochester, Minn.
- Division of Allergic Diseases, Mayo Clinic, Rochester, Minn.
- Division of Allergic Diseases, Mayo Clinic, Scottsdale, Ariz.
Förderung
- NHLBI NIH HHS
- NIAID NIH HHS
- National Institutes of Health
Zitieren
APA
Juhn, Y. J., Wi, C. I., Ryu, E., King, K. S., Sohn, S., Sagheb, E., Jenkins, G., Watson, D., Park, M. A., Chiarella, S. E., Kita, H., Ali, M., Huskins, W. C., Ristagno, E. H., Absah, I., Grose, C., Ihrke, K., Krusemark, E. A., Pongdee, T., …, & Liu, H. (2025). Artificial intelligence biomarker detects high-risk childhood asthma subgroup for respiratory infections and exacerbations. Journal of Allergy and Clinical Immunology, 156(6), 1547-1555.e4. https://doi.org/10.1016/j.jaci.2025.07.031
Vancouver
Juhn YJ, Wi CI, Ryu E, King KS, Sohn S, Sagheb E, et al. Artificial intelligence biomarker detects high-risk childhood asthma subgroup for respiratory infections and exacerbations. Journal of Allergy and Clinical Immunology. 2025;156(6):1547-1555.e4. doi:10.1016/j.jaci.2025.07.031
BibTeX
@article{Juhn2025,
author = {Juhn, Young J and Wi, Chung-Il and Ryu, Euijung and King, Katherine S and Sohn, Sunghwan and Sagheb, Elham and Jenkins, Greg and Watson, David and Park, Miguel A and Chiarella, Sergio E and Kita, Hirohito and Ali, Mir and Huskins, W Charles and Ristagno, Elizabeth H and Absah, Imad and Grose, Charles and Ihrke, Kathy and Krusemark, Elizabeth A and Pongdee, Thanai and Nordlund, Björn and Davis, Carla M and Pignolo, Robert J and Liu, Hongfang},
title = {Artificial intelligence biomarker detects high-risk childhood asthma subgroup for respiratory infections and exacerbations},
journal = {Journal of Allergy and Clinical Immunology},
year = {2025},
volume = {156},
number = {6},
pages = {1547--1555.e4},
doi = {10.1016/j.jaci.2025.07.031}
}
EUVIMED